Found: 32
Select item for more details and to access through your institution.
Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Baseline amyloid and tau PET imaging characteristics in the ongoing phase 2 study of tilavonemab in early Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052183
- By:
- Publication type:
- Article
A three‐dimensional neuroimaging based deep learning model to predict Alzheimer's disease progression for clinical trial design.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052345
- By:
- Publication type:
- Article
A Comparison of Gray Matter Density in Restless Legs Syndrome Patients and Matched Controls Using Voxel-Based Morphometry.
- Published in:
- Journal of Neuroimaging, 2012, v. 22, n. 1, p. 28, doi. 10.1111/j.1552-6569.2010.00536.x
- By:
- Publication type:
- Article
ON EVALUATION OF TAU ACCUMULATIONS IN LONGITUDINAL STUDIES OF ALZHEIMER’S DISEASE (AD): IMPLICATIONS FROM A PET STUDY WITH [18F]RO6958948.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P139, doi. 10.1016/j.jalz.2017.06.2563
- By:
- Publication type:
- Article
Kinetic evaluation of three newly developed radioligands for human tau imaging.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2015, v. 11, n. 7, p. P851, doi. 10.1016/j.jalz.2015.08.014
- By:
- Publication type:
- Article
Trial by MRI.
- Published in:
- 2011
- By:
- Publication type:
- Letter
[<sup>18</sup>F]BTK-1: A Novel Positron Emission Tomography Tracer for Imaging Bruton's Tyrosine Kinase.
- Published in:
- Molecular Imaging & Biology, 2022, v. 24, n. 5, p. 830, doi. 10.1007/s11307-022-01733-1
- By:
- Publication type:
- Article
Test–retest variability and reference region-based quantification of 18 F-BCPP-EF for imaging mitochondrial complex I in the human brain.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 4, p. 771, doi. 10.1177/0271678X20928149
- By:
- Publication type:
- Article
Quantification of [<sup>11</sup>C]Ro15-4513 GABA<sub>A</sub>α5 specific binding and regional selectivity in humans.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2017, v. 37, n. 6, p. 2137, doi. 10.1177/0271678X16661339
- By:
- Publication type:
- Article
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 3, p. 382, doi. 10.1007/s00259-016-3510-6
- By:
- Publication type:
- Article
Increased arterial inflammation in individuals with stage 3 chronic kidney disease.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 2, p. 333, doi. 10.1007/s00259-015-3203-6
- By:
- Publication type:
- Article
Author Correction: Synaptic loss and its association with symptom severity in Parkinson's disease.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Synaptic loss and its association with symptom severity in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00655-9
- By:
- Publication type:
- Article
Monoamine oxidase B inhibitor, selegiline, reduces <sup>18</sup>F-THK5351 uptake in the human brain.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0253-y
- By:
- Publication type:
- Article
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Visual Interpretation Algorithm for Assessing Brain Tauopathy with <sup>18</sup>F-MK-6240 PET.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 444, doi. 10.2967/jnumed.122.264371
- By:
- Publication type:
- Article
A Visual Interpretation Algorithm for Assessing Brain Tauopathy with18-F MK-6240 Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264371
- By:
- Publication type:
- Article
Characterization of 3 PET tracers for Quantification of Mitochondrial and Synaptic function in Healthy Human Brain: <sup>18</sup>F-BCPP-EF, <sup>11</sup>C-SA-4503, <sup>11</sup>C-UCB-J.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.228080
- By:
- Publication type:
- Article
Characterization of 3 Novel Tau Radiopharmaceuticals, <sup>11</sup>C-RO-963, <sup>11</sup>C-RO-643, and <sup>18</sup>F-RO-948, in Healthy Controls and in Alzheimer Subjects.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 12, p. 1869, doi. 10.2967/jnumed.118.209916
- By:
- Publication type:
- Article
Evaluation of <sup>18</sup>F-RO-948 PET for Quantitative Assessment of Tau Accumulation in the Human Brain.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 12, p. 1877, doi. 10.2967/jnumed.118.214437
- By:
- Publication type:
- Article
Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1124, doi. 10.2967/jnumed.116.182881
- By:
- Publication type:
- Article
Human Kinetic Modeling of the 5HT6 PET Radioligand <sup>11</sup>C-GSK215083 and Its Utility for Determining Occupancy at Both 5HT6 and 5HT2A Receptors by SB742457 as a Potential Therapeutic Mechanism of Action in Alzheimer Disease.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 12, p. 1901, doi. 10.2967/jnumed.115.162743
- By:
- Publication type:
- Article
Radiosynthesis and Characterization of <sup>11</sup>C-GSK215083 as a PET Radioligand for the 5-HT6 Receptor.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 2, p. 295, doi. 10.2967/jnumed.111.093419
- By:
- Publication type:
- Article
Evaluation of <sup>11</sup>C-GSK189254 as a Novel Radioligand for the H<sub>3</sub> Receptor in Humans Using PET.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 7, p. 1021, doi. 10.2967/jnumed.109.071753
- By:
- Publication type:
- Article
Kinetic Modeling of <sup>11</sup>C-SB207145 Binding to 5-HT<sub>4</sub> Receptors in the Human Brain In Vivo.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 6, p. 900, doi. 10.2967/jnumed.108.058552
- By:
- Publication type:
- Article
Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87307-7
- By:
- Publication type:
- Article
A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 1, p. 77, doi. 10.3390/diagnostics12010077
- By:
- Publication type:
- Article
Widespread cell stress and mitochondrial dysfunction occur in patients with early Alzheimer's disease.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 658, p. 1, doi. 10.1126/scitranslmed.abk1051
- By:
- Publication type:
- Article
The application of positron emission tomography (PET) imaging in CNS drug development.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Biodistribution and Radiation Dosimetry of the Serotonin 5-HT Ligand [C]GSK215083 Determined from Human Whole-Body PET.
- Published in:
- Molecular Imaging & Biology, 2012, v. 14, n. 4, p. 517, doi. 10.1007/s11307-011-0523-1
- By:
- Publication type:
- Article